, Current Concepts in Pediatric Liver Transplant, Semin Liver Dis, vol.18, pp.295-307, 1998.
, Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice, EMBO Mol Med, vol.5, pp.1684-1697, 2013.
,
, One Standardized Differentiation Procedure Robustly Generates Homogenous, 2016.
, Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells, Stem Cell Rev and Rep, vol.12, pp.90-104
, Efficient generation of transgenefree human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci U S A, vol.108, pp.14234-14239, 2011.
,
,
,
, Phenotypic and functional analyses show stem cell-derived hepatocytelike cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, pp.581-589, 2015.
,
, Liver cell transplantation in severe infantile oxalosis-a potential bridging procedure to orthotopic liver transplantation?, Nephrol Dial Transplant, vol.27, pp.2984-2989, 2012.
,
, Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors, Am J Hum Genet, vol.91, pp.109-121, 2012.
, Transplantation Outcomes in Primary Hyperoxaluria, Am J Transplant, vol.10, pp.2493-2501, 2010.
,
,
, Liver-Directed Lentiviral Gene Therapy in a Dog Model of Hemophilia B, Sci Transl Med, vol.7, pp.277-305, 2015.
, , 2016.
, Gene Ther, vol.23, pp.129-134
, Gene therapy for severe combined immunodeficiency: are we there yet?, J Clin Invest, vol.117, pp.1456-1465, 2007.
, Primary hyperoxaluria type 1: strategy for organ transplantation. Current Opinion in, Organ Transplantation, vol.15, pp.590-593, 2010.
, Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment, Nephrol Dial Transplant, vol.27, pp.1729-1736, 2012.
, Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6, J Inherit Metab Dis, vol.41, pp.263-275, 2018.
, Memory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information, Special issue: viruses of microbes, vol.434, pp.202-209, 2012.
, Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions, Experimental Cell Research, vol.352, pp.333-345, 2017.
, A transcriptomic study suggesting human iPSC-derived hepatocytes, 2017.
, Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines, Stem Cells Int, 2016.
, CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism, Annual Review of Pharmacology and Toxicology, vol.39, pp.1-17, 1999.
, Production of hepatocyte like cells from human pluripotent stem cells, Nat Protoc, vol.8, pp.430-437, 2013.
, Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome, Kidney International, vol.77, pp.443-449, 2010.
, Primary Hyperoxaluria, Int J Nephrol, 2011.
, The Primary Hyperoxalurias, Kidney Int, vol.75, pp.1264-1271, 2009.
, Correction of Hyperoxaluria by Liver Repopulation With Hepatocytes in a Mouse Model of Primary Hyperoxaluria Type-1, Transplantation, vol.85, pp.1253-1260, 2008.
, A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity, Science, vol.337, pp.816-821, 2012.
, Highly efficient gene transfer into hepatocyte-like HepaRG cells: new means for drug metabolism and toxicity studies, Biotechnol J, vol.5, pp.314-320, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00552337
, Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells, Mol Ther Nucleic Acids, vol.5, p.394, 2016.
, The consensus-based approach for gene/enzyme replacement therapies and crystallization strategies: the case of human alanine-glyoxylate aminotransferase, Biochemical Journal, vol.462, pp.453-463, 2014.
, High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors, Blood, vol.98, pp.2664-2672, 2001.
, Assessment of risk of cancer after renal transplantation, The Lancet, vol.351, pp.610-611, 1998.
, Therapeutic Lentivirus-Mediated Neonatal in Vivo Gene Therapy in Hyperbilirubinemic Gunn Rats, Molecular Therapy, vol.12, pp.852-859, 2005.
, Safety of intra-articular transplantation of lentivirally transduced, 2018.
, Induced pluripotent stem cells: opportunities and challenges, 2011.
, Philos Trans R Soc Lond B Biol Sci, vol.366, pp.2198-2207
, CRISPR/Cas9: at the cutting edge of hepatology, Gut, vol.66, pp.1329-1340, 2017.
, Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J Clin Invest, vol.120, pp.3127-3136, 2010.
, Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection, Gene Therapy, vol.11, pp.1638-1647, 2004.
, Hepatocyte-like cells derived from induced pluripotent stem cells, Hepatol Int, vol.11, pp.54-69, 2017.
, Phenotypic Correction of a Mouse Model for Primary Hyperoxaluria With Adeno-associated Virus Gene Transfer, Mol Ther, vol.19, pp.870-875, 2011.
, Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer, Proc Natl Acad Sci U S A, vol.103, pp.18249-18254, 2006.
, Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase, Proc Natl Acad Sci U S A, vol.100, pp.7277-7282, 2003.
, Lentiviral Vectors That Express UGT1A1 in Liver and Contain miR-142 Target Sequences Normalize Hyperbilirubinemia in Gunn Rats, Gastroenterology, vol.139, pp.999-1007, 2010.
, Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors, Cell, vol.131, pp.861-872, 2007.
, Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research, Biomaterials, vol.161, pp.24-32, 2018.
, Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells, Int J Mol Sci, vol.18, 2017.
, Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation, Stem Cell Research, vol.16, pp.116-119, 2016.
, Supplemental Figure S3. Representative karyotype analysis of WT-iPSC#1, vol.46
, The Primary Hyperoxalurias, Kidney Int, vol.75, pp.1264-1271, 2009.
, The consensus-based approach for gene/enzyme replacement therapies and crystallization strategies: the case of human alanineglyoxylate aminotransferase, Biochemical Journal, vol.462, pp.453-463, 2014.
, Primary hyperoxaluria type 1: strategy for organ transplantation. Current Opinion in, Organ Transplantation, vol.15, pp.590-593, 2010.
, Recent advances in liver transplantation for metabolic disease, J Inherit Metab Dis, vol.40, pp.491-495, 2017.
, Clinical Hepatocyte Transplantation: What Is Next?, Curr Transplant Rep, vol.4, pp.280-289, 2017.
, Highly Efficient Generation of Human Hepatocyte-like Cells from Induced Pluripotent Stem Cells, Hepatology, vol.51, pp.297-305, 2010.
, Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J Clin Invest, vol.120, pp.3127-3136, 2010.
, Production of hepatocyte like cells from human pluripotent stem cells, Nat Protoc, vol.8, pp.430-437, 2013.
, AGXT expression rescue in hepatocyte-like cells derived from Primary Hyperoxaluria type 1 induced pluripotent stem cells using liver-specific lentiviral vector, Stem Cell Res Submitted, 2018.
, Ex vivo gene transfer and correction for cell-based therapies, Nat Rev Genet, vol.12, pp.301-315, 2011.
, Genome engineering with targetable nucleases, Annu Rev Biochem, vol.83, pp.409-439, 2014.
, Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration, Stem Cells, vol.26, pp.496-504, 2008.
, Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives, Methods, vol.101, pp.43-55, 2016.
, One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells, Stem Cell Rev and Rep, vol.12, pp.90-104, 2016.
, RNA-Guided Human Genome Engineering via Cas9, Science, vol.339, pp.823-826, 2013.
, Genetic screens in human cells using the CRISPR/Cas9 system, Science, vol.343, pp.80-84, 2014.
, Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery, Nature Methods, vol.13, pp.41-50, 2016.
, Targeted integration of adeno-associated virus (AAV) into human chromosome 19, EMBO J, vol.10, pp.3941-3950, 1991.
, Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome, Genome Res, vol.20, pp.1133-1142, 2010.
, Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells, Gene Ther, vol.20, pp.201-214, 2013.
, Site-specific integration and tailoring of cassette design for sustainable gene transfer, Nat Methods, vol.8, pp.861-869, 2011.
, Biased and Unbiased Methods for the Detection of Off-Target Cleavage by CRISPR/Cas9: An Overview, Int J Mol Sci, vol.17, 2016.
, Phenotypic and functional analyses show stem cellderived hepatocyte-like cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, pp.581-589, 2015.
, CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism, Annual Review of Pharmacology and Toxicology, vol.39, pp.1-17, 1999.
, Isolated human hepatocytes in culture display markedly different gene expression patterns depending on attachment status, Toxicology in Vitro, vol.17, pp.693-701, 2003.
, Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes, Drug Metab Dispos, vol.31, pp.421-431, 2003.
, Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase, Proc Natl Acad Sci U S A, vol.100, pp.7277-7282, 2003.
, Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition, Stem Cell Reports, vol.5, pp.918-931, 2015.
, Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer, Proc Natl Acad Sci, vol.103, pp.18249-18254, 2006.
, Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX, Cell Rep, vol.23, pp.1565-1580, 2018.
, Calculs multiples chez un enfant: Infiltration du parenchyme rénal par des dépots cristallins, J Urol, 1925.
, New England Journal of Medicine, vol.369, pp.649-658, 2013.
, Hyperoxalurie primitive : une revue de la littérature, Néphrologie & Thérapeutique, vol.12, pp.431-436, 2016.
, The Primary Hyperoxalurias, Kidney Int, vol.75, pp.1264-1271, 2009.
, Primary hyperoxalurias: Disorders of glyoxylate detoxification, Biochimica et Biophysica Acta, pp.1453-1464, 2012.
, Mitochondrial Hydroxyproline Metabolism: Implications for Primary Hyperoxaluria, AJN, vol.25, pp.171-175, 2005.
, Human wild-type alanine: glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications, Biochemical Journal, vol.408, pp.39-50, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00478801
, Molecular therapy of primary hyperoxaluria, J Inherit Metab Dis, vol.40, pp.481-489, 2017.
, Pxmp2 Is a Channel-Forming Protein in Mammalian Peroxisomal Membrane, PLOS ONE, vol.4, p.5090, 2009.
, The Primary Hyperoxalurias, JASN, vol.12, 1986.
, Int J Nephrol, 2011.
, Combined Liver-Kidney Transplantation for Primary Hyperoxaluria Type 2: A Case Report, American Journal of Transplantation, vol.18, pp.253-257, 2018.
, Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2, Pediatr Transplant, vol.18, pp.69-73, 2014.
, Primary Hyperoxaluria Type 2. in GeneReviews®, 1993.
, Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria, J Am Soc Nephrol, vol.26, pp.2559-2570, 2015.
, Structural and Biochemical Studies of Human 4-hydroxy-2-oxoglutarate Aldolase: Implications for Hydroxyproline Metabolism in Primary Hyperoxaluria, PLoS One, vol.6, 2011.
, 4-Hydroxy-2-oxoglutarate Aldolase Inactivity in Primary Hyperoxaluria Type 3 and Glyoxylate Reductase Inhibition, Biochim Biophys Acta, vol.1822, pp.1544-1552, 2012.
, Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique, Nephrol. Dial. Transplant, vol.10, pp.3-7, 1995.
, Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association -European Renal Association, vol.18, pp.273-282, 2003.
, Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy, vol.7, pp.458-465, 2012.
, End-stage renal disease in Kuwaiti children: An 8-year experience, Transplantation proceedings, vol.36, pp.1788-91, 2004.
, End-stage renal disease of the Tunisian child: Epidemiology, etiologies, and outcome, Pediatr. Nephrol, vol.10, pp.479-482, 1996.
, Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital, Saudi Journal of Kidney Diseases and Transplantation, vol.29, p.30, 2018.
, Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience, Kidney International, vol.70, pp.1115-1119, 2006.
, Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type, Kidney International, vol.86, pp.1197-1204, 2014.
, Primary hyperoxaluria Type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort, Nephrol Dial Transplant, vol.27, pp.3855-3862, 2012.
, Primary Hyperoxaluria Remains Undiagnosed in Patients with Hyperoxaluria and Recurrent Urolithiasis, Clinical Chemistry, vol.53, pp.1553-1555, 2007.
, Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure, Kidney International, vol.48, pp.182-187, 1995.
, Skeletal manifestations of primary oxalosis, Pediatr. Nephrol, vol.5, pp.193-199, 1991.
, Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in primary hyperoxaluria type 1, Am. J. Kidney Dis, vol.21, pp.54-63, 1993.
, Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment, Nephrol Dial Transplant, vol.27, pp.1729-1736, 2012.
, Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria, Muscle Nerve, vol.51, pp.449-454, 2015.
, Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I, FEBS Letters, vol.201, pp.20-34, 2001.
, The organ distribution of human alanine-2-oxoglutarate aminotransferase and alanine-glyoxylate aminotransferase, Biochem Med, pp.25-34, 1980.
, Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview, Biochimica et Biophysica Acta (BBA) -Proteins and Proteomics, vol.1854, pp.1212-1219, 2015.
, Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B<Subscript>6</Subscript>, J Inherit Metab Dis, vol.41, pp.263-275, 2018.
, Crystal Structure of Alanine:Glyoxylate Aminotransferase and the Relationship Between Genotype and Enzymatic Phenotype in Primary Hyperoxaluria Type 1, Journal of Molecular Biology, vol.331, pp.643-652, 2003.
, The chaperone role of the pyridoxal 5?-phosphate and its implications for rare diseases involving B6-dependent enzymes, Clinical Biochemistry, vol.47, pp.158-165, 2014.
, Peroxisomal Import of Human Alanine:glyoxylate Aminotransferase Requires Ancillary Targeting Information Remote from Its C Terminus, J. Biol. Chem, vol.280, pp.27111-27120, 2005.
, Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1, J Cell Biol, pp.95-109, 1995.
, The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase, The International Journal of Biochemistry & Cell Biology, vol.44, pp.536-546, 2012.
, Accessed: 9th August 2018) 43. Pubchem. Pyridoxal phosphate anhydrous, p.9, 2018.
, Characterization and chromosomal mapping of a genomic clone encoding human alanine:Glyoxylate aminotransferase, Genomics, vol.10, pp.34-42, 1991.
, Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation, Proc Natl Acad Sci U S A, vol.88, pp.10900-10904, 1991.
, Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1, The Journal of Cell Biology, vol.111, pp.2341-2351, 1990.
, Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity, J. Inherit. Metab. Dis, vol.17, pp.487-499, 1994.
, Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT), J. Inherit. Metab. Dis, vol.20, pp.689-696, 1997.
, Functional Synergism between the Most Common Polymorphism in Human Alanine:Glyoxylate Aminotransferase and Four of the Most Common Disease-causing Mutations, J. Biol. Chem, vol.275, pp.36415-36422, 2000.
, Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant, Biochimie, vol.92, pp.1801-1811, 2010.
, In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine:Glyoxylate Aminotransferase, J Biol Chem, vol.283, pp.30493-30502, 2008.
, Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria, Amino Acids, vol.41, pp.1233-1245, 2011.
, Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene, Human Mutation, vol.30, pp.910-917, 2009.
, Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants, MGM, vol.94, pp.368-374, 2008.
, Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: Study of a spectrum of mutations, MGM, vol.89, pp.349-359, 2006.
, S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation, Hum Mol Genet, vol.23, pp.5998-6007, 2014.
, Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation, J Biol Chem, vol.284, pp.8349-8358, 2009.
, Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I, Mol Genet Metab, vol.105, pp.132-140, 2012.
, The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I, PLoS One, vol.8, 2013.
, Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications, Proteins, vol.81, pp.1457-1465, 2013.
, Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I, PNAS, vol.107, pp.2896-2901, 2010.
, Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele, J Biol Chem, vol.288, pp.2475-2484, 2013.
, Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase, Proc Natl Acad Sci U S A, vol.100, pp.7277-7282, 2003.
, Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase, Biochimica et Biophysica Acta, pp.2277-2288, 2013.
, An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria, J Cell Biol, vol.108, pp.1345-1352, 1989.
, International Registry for Primary Hyperoxaluria, AJN, vol.25, pp.290-296, 2005.
, Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome, Kidney International, vol.77, pp.443-449, 2010.
, Implications of Genotype and Enzyme Phenotype in Pyridoxine Response of Patients with Type I Primary Hyperoxaluria, AJN, vol.25, pp.183-188, 2005.
, Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias1, Kidney International, vol.66, pp.959-963, 2004.
, Intra-Familial Clinical Heterogeneity: Absence of Genotype-Phenotype Correlation in Primary Hyperoxaluria Type 1 in Israel, AJN, vol.25, pp.269-275, 2005.
, Hereditary Causes of Kidney Stones and Chronic Kidney Disease, Pediatr Nephrol, vol.28, pp.1923-1942, 2013.
, Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease, Clinical Biochemistry, vol.50, pp.1014-1019, 2017.
, The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury, Kidney International, vol.93, pp.656-669, 2018.
, A Semiautomated Alanine: Glyoxylate Aminotransferase Assay for the Tissue Diagnosis of Primary Hyperoxaluria Type 1, Ann Clin Biochem, vol.34, pp.400-404, 1997.
, Urinary Volume, Water and Recurrences in Idiopathic Calcium Nephrolithiasis: A 5-year Randomized Prospective Study, The Journal of Urology, vol.155, pp.839-843, 1996.
, 13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria, Kidney International, vol.73, pp.1181-1186, 2008.
, Metabolic profile and impact of diet in patients with primary hyperoxaluria, Int Urol Nephrol, pp.1-7, 2018.
, Contribution of dietary oxalate to urinary oxalate excretion, Kidney International, vol.59, pp.270-276, 2001.
, Dependence of Oxalate Absorption on the Daily Calcium Intake, JASN, vol.15, pp.1567-1573, 2004.
, Management of primary hyperoxaluria: efficacy of oral citrate administration, Pediatr. Nephrol, vol.7, pp.207-211, 1993.
, Prevention of Stone Formation and Bone Loss In Absorptive Hypercalciuria by Combined Dietary and Pharmacological Interventions, The Journal of Urology, vol.169, pp.465-469, 2003.
, Importance of Magnesium in Absorption and Excretion of Oxalate, UIN, vol.74, pp.262-267, 2005.
, Nefrologia, vol.34, pp.398-412, 2014.
, The action of pyridoxine in primary hyperoxaluria, Clin Sci, pp.277-286, 1970.
, The effect of Pyridoxine on Oxalate Dynamics in three Cases of Primary Hyperoxaluria (with Glycollic Aciduria), Clinical Science, vol.69, pp.87-90, 1985.
, Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice, Clin J Am Soc Nephrol, vol.9, pp.468-477, 2014.
, Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele, Kidney International, vol.67, pp.1704-1709, 2005.
, Clinical implications of mutation analysis in primary hyperoxaluria type 1, Kidney International, vol.66, pp.746-752, 2004.
, Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1. Biochimica et Biophysica Acta (BBA) -Molecular Basis of Disease 1832, pp.1776-1783, 2013.
, Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1, Kidney International, vol.76, pp.767-773, 2009.
, Pediatric urolithiasis: the current surgical management, Pediatr Nephrol, vol.25, pp.1239-1244, 2010.
, Endourologic treatment of nephrocalcinosis, Urology, vol.56, p.508, 2000.
, Hyperoxaluria and renal calculi in children: the role of extracorporeal shock wave lithotripsy, J R Soc Med, vol.81, pp.604-605, 1988.
, Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1, Kidney International, vol.70, pp.1642-1648, 2006.
, Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria, Am. J. Kidney Dis, vol.19, pp.546-553, 1992.
, Primary hyperoxaluria type 1: still challenging!, Pediatr Nephrol, vol.21, pp.1075-1081, 2006.
, Successful strategies for renal transplantation in primary oxalosis, Kidney Int, vol.25, pp.804-811, 1984.
, Transplantation outcomes in primary hyperoxaluria, Am. J. Transplant, vol.10, pp.2493-2501, 2010.
, Recurrence of oxalate nephropathy after isolated kidney transplantation for primary hyperoxaluria type 2, American Journal of Transplantation, vol.18, pp.525-526, 2018.
, Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth, Transplantation, vol.87, pp.1415-1421, 2009.
, Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration, Nephrol. Dial. Transplant, vol.26, pp.354-359, 2011.
, European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004, Am. J. Nephrol, vol.25, pp.282-289, 2005.
, Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: The French Experience, Liver Transplantation, vol.20, pp.1475-1485, 2014.
, Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation, Pediatr Transplant, vol.13, pp.782-784, 2009.
, The role of preemptive liver transplantation in primary hyperoxaluria type 1, Urol Res, vol.33, pp.376-379, 2005.
, Left Lateral Sectionectomy of the Native Liver and Combined Living-Related Liver-Kidney Transplantation for Primary Hyperoxaluria Type, Medicine (Baltimore), vol.1, 2015.
, Primary Hyperoxaluria Type 1. in GeneReviews®, 2017.
, Phenotypic Correction of a Mouse Model for Primary Hyperoxaluria With Adeno-associated Virus Gene Transfer, Mol Ther, vol.19, pp.870-875, 2011.
, Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1, Gene Ther, vol.23, pp.129-134, 2016.
, Le guide santé de référence sur le fonctionnement de votre corps, 2015.
, Thérapie cellulaire. Inserm Available, p.27, 2018.
, Development of a new microfluidic platform in order to study intestinal and hepatic first pass effects, p.8, 2018.
, Anatomie du foie -Cancer du foie, p.8, 2018.
, Exploiting the unique regenerative capacity of the liver to underpin cell and gene therapy strategies for genetic and acquired liver disease, The International Journal of Biochemistry & Cell Biology, vol.56, pp.141-152, 2014.
, Cell therapy for liver disease: From liver transplantation to cell factory, Journal of Hepatology, vol.62, pp.157-169, 2015.
, Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer, Proc Natl Acad Sci U S A, vol.103, pp.18249-18254, 2006.
, Feasibility of Hepatocyte Transplantation-Based Therapies for Primary Hyperoxalurias, AJN, vol.25, pp.161-170, 2005.
, Correction of Hyperoxaluria by Liver Repopulation With Hepatocytes in a Mouse Model of Primary Hyperoxaluria Type-1, Transplantation, vol.85, pp.1253-1260, 2008.
, Liver cell transplantation in severe infantile oxalosis-a potential bridging procedure to orthotopic liver transplantation?, Nephrol Dial Transplant, vol.27, pp.2984-2989, 2012.
, Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: a case report, Trop Gastroenterol, vol.25, pp.141-143, 2004.
, Human fetal hepatocyte transplantation in patients with fulminant hepatic failure, Transplantation, vol.58, pp.951-952, 1994.
, Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes, J Hepatol, vol.62, pp.581-589, 2015.
, Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-Enhancer Urokinase-Type Plasminogen Activator Mice, Am J Pathol, vol.175, pp.1483-1492, 2009.
, Activation of stem cells in hepatic diseases, Cell Tissue Res, vol.331, pp.283-300, 2008.
, Human hepatic progenitor cells express hematopoietic cell markers CD45 and CD109, Int J Med Sci, vol.11, pp.65-79, 2014.
, Adult Hepatocytes Are Generated by Self-Duplication Rather than Stem Cell Differentiation, Cell Stem Cell, vol.15, pp.340-349, 2014.
, Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes, Cell Stem Cell, vol.15, pp.605-618, 2014.
, Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes, Cell Stem Cell, vol.14, pp.370-384, 2014.
, Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming, Cell Stem Cell, vol.14, pp.394-403, 2014.
, Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts, Sci Rep, vol.5, 2015.
, Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors, Cell, vol.131, pp.861-872, 2007.
, Contemporary Approaches for Nonviral Gene Therapy, Discovery Medicine, vol.19, pp.447-454, 2015.
, , p.27, 2018.
, Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects, J Inherit Metab Dis, vol.40, pp.497-517, 2017.
, Gene Therapy Clinical Trials Worldwide. Available, p.27, 2018.
, Thérapie génique du déficit immunitaire combiné sévère lié à l'X -Efficacité et complications, Med Sci, vol.20, pp.115-117, 2004.
, Retroviral proteases and their roles in virion maturation, Virology, vol.479, issue.480, pp.403-417, 2015.
, Lentiviral Vectors in Immunotherapy, Gene Therapy -Tools and Potential Applications, 2013.
, Gene Therapy Review. Available, p.1, 2018.
, , 1995.
, On the general theory of the origins of retroviruses, Theor Biol Med Model, vol.7, p.5, 2010.
, T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years, Science, vol.270, pp.475-480, 1995.
, Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Science, vol.288, pp.669-672, 2000.
, Gene therapy for severe combined immunodeficiency: are we there yet?, J Clin Invest, vol.117, pp.1456-1465, 2007.
, Explanatory chapter: introducing exogenous DNA into cells, Meth. Enzymol, vol.529, pp.29-34, 2013.
, Therapeutic Lentivirus-Mediated Neonatal in Vivo Gene Therapy in Hyperbilirubinemic Gunn Rats, Molecular Therapy, vol.12, pp.852-859, 2005.
, Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease, J. Mol. Neurosci, vol.61, pp.489-497, 2017.
, Genotoxicity of retroviral integration in hematopoietic cells, Mol. Ther, vol.13, pp.1031-1049, 2006.
, Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice, Hum. Mol. Genet, vol.24, pp.2287-2296, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01350897
, Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells, Exp. Hematol, vol.43, pp.346-351, 2015.
, Liver-Directed Lentiviral Gene Therapy in a Dog Model of Hemophilia B, Sci Transl Med, vol.7, pp.277-305, 2015.
, Lentiviral Vectors That Express UGT1A1 in Liver and Contain miR-142 Target Sequences Normalize Hyperbilirubinemia in Gunn Rats, Gastroenterology, vol.139, pp.999-1007, 2010.
, A Step Toward Liver Gene Therapy: Efficient Correction of the Genetic Defect of Hepatocytes Isolated From a Patient With Crigler-Najjar Syndrome Type 1 With Lentiviral Vectors, Transplantation, vol.87, p.1006, 2009.
, Exon-skipping advances for Duchenne muscular dystrophy, Hum Mol Genet, vol.27, pp.163-172, 2018.
, Functional repair of p53 mutation in colorectal cancer cells using trans-splicing, Oncotarget, vol.6, pp.2034-2045, 2015.
, Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo, Sci Rep, vol.5, 2015.
, Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations, Gene Therapy, vol.23, pp.775-784, 2016.
, Viruses in recreational water-borne disease outbreaks: a review, J. Appl. Microbiol, vol.107, pp.1769-1780, 2009.
, Gutless adenovirus: last-generation adenovirus for gene therapy, Gene Therapy, vol.12, pp.18-27, 2005.
, China approves first gene therapy, Nat. Biotechnol, vol.22, pp.3-4, 2004.
, Progress and Prospects: Immune Responses to Viral Vectors, Gene Ther, vol.17, pp.295-304, 2010.
, Gene Therapy Using Adeno-Associated Virus Vectors, Clin Microbiol Rev, vol.21, pp.583-593, 2008.
, Kinetics and Frequency of Adeno-Associated Virus SiteSpecific Integration into Human Chromosome 19 Monitored by Quantitative Real-Time PCR, J Virol, vol.76, pp.7554-7559, 2002.
, Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination, EMBO J, vol.11, pp.5071-5078, 1992.
, Viral vector-mediated gene therapies, Curr. Opin. Neurol, vol.28, pp.522-527, 2015.
, Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency, Expert Opin Biol Ther, vol.13, pp.7-10, 2013.
, Children's Medical Research Institute, p.28, 2018.
, Pompe Disease: Literature Review and Case Series, Neurologic Clinics, vol.32, pp.751-776, 2014.
, Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria, Journal of Medical Genetics, vol.51, pp.526-529, 2014.
, Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I, Mol Ther, vol.24, pp.719-725, 2016.
, Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1, Mol Ther, vol.24, pp.770-778, 2016.
, An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria, J Am Soc Nephrol, vol.28, pp.494-503, 2017.
, Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1 -Full Text View -ClinicalTrials.gov. Available at, p.11, 2018.
, An Extension Study of an Investigational Drug, ALN-GO1, in Patients With Primary Hyperoxaluria Type 1 -No Study Results Posted -ClinicalTrials, p.15, 2018.
, A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 -Full Text View -ClinicalTrials.gov, p.11, 2018.
, RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?, Annual Review of Pharmacology and Toxicology, vol.56, pp.103-122, 2016.
, Evolution of a gene. Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function and regulation, Science, vol.189, pp.102-114, 1975.
, Targeting lactate metabolism for cancer therapeutics, J. Clin. Invest, vol.123, pp.3685-3692, 2013.
, Erythematosquamous Skin Lesions in Hereditary Lactate Dehydrogenase M-Subunit Deficiency, vol.122, pp.1420-1424, 1986.
, Hereditary lactate dehydrogenase M-subunit deficiency: Lactate dehydrogenase activity in skin lesions and in hair follicles, Journal of the American Academy of Dermatology, vol.24, pp.339-342, 1991.
, Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy, Clin. Chim. Acta, vol.173, pp.89-98, 1988.
, Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria, Molecular Therapy, vol.26, 1983.
, Hydroxyproline metabolism in mouse models of primary hyperoxaluria, Am J Physiol Renal Physiol, vol.302, pp.688-693, 2012.
, Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria -Full Text View -ClinicalTrials.gov. Available at, p.11, 2018.
, Novel Investigational Drug for PH: DCR-PHXC. Dicerna Pharmaceuticals Available at, p.11, 2018.
, Enzyme replacement therapy for lysosomal storage diseases, Pediatr Endocrinol Rev, vol.10, issue.1, pp.26-34, 2012.
, Pompe disease treatment with twice a week high dose alglucoside alfa in a patient with severe dilated cardiomyopathy, Mol Genet Metab Rep, vol.16, pp.1-4, 2018.
, Molecular Recognition of PTS-1 Cargo Proteins by Pex5p: Implications for Protein Mistargeting in Primary Hyperoxaluria, Biomolecules, vol.5, pp.121-141, 2015.
, Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I, Nanomedicine: Nanotechnology, Biology and Medicine, vol.13, pp.897-907, 2017.
, The consensus-based approach for gene/enzyme replacement therapies and crystallization strategies: the case of human alanine-glyoxylate aminotransferase, Biochemical Journal, vol.462, pp.453-463, 2014.
, Physiological Roles of Asialoglycoprotein Receptors (ASGPRs) Variants and Recent Advances in Hepatic-Targeted Delivery of Therapeutic Molecules Via ASGPRs, Protein & Peptide Letters, p.14, 2014.
, Targeted Delivery and Improved Therapeutic Potential of Catalase by Chemical Modification: Combination with Superoxide Dismutase Derivatives, J Pharmacol Exp Ther, vol.289, pp.1176-1184, 1999.
, Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics, Advanced Drug Delivery Reviews, vol.59, pp.739-747, 2007.
, Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence, Peptides, vol.37, pp.273-284, 2012.
, Chaperone machines for protein folding, unfolding and disaggregation, Nat Rev Mol Cell Biol, vol.14, pp.630-642, 2013.
, Protein Homeostasis Defects of Alanine-Glyoxylate Aminotransferase: New Therapeutic Strategies in Primary Hyperoxaluria Type I, Biomed Res Int, 2013.
, Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening, ASSAY and Drug Development Technologies, vol.13, pp.16-24, 2015.
, Drug Library Screening for the Identification of Ionophores That Correct the Mistrafficking Disorder Associated with Oxalosis Kidney Disease, SLAS DISCOVERY: Advancing Life Sciences R&D, vol.22, pp.887-896, 2017.
, Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1, Proc Natl Acad Sci U S A, vol.111, pp.14406-14411, 2014.
, Translation inhibition corrects aberrant localization of mutant alanineglyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria, J Mol Med, vol.96, pp.621-630, 2018.
, A Novel Approach to Recovery of Function of Mutant Proteins by Slowing Down Translation, J Biol Chem, vol.287, pp.34264-34272, 2012.
, Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract, Arch. Microbiol, vol.141, pp.1-7, 1985.
, Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter, Am J Physiol Gastrointest Liver Physiol, vol.300, pp.461-469, 2011.
, Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion, Kidney International, vol.69, pp.691-698, 2006.
, A Human Strain of Oxalobacter (HC-1) Promotes Enteric Oxalate Secretion in the Small Intestine of Mice and Reduces Urinary Oxalate Excretion, Urolithiasis, vol.41, 2013.
, Oxalobacter formigenes and its role in oxalate metabolism in the human gut, FEMS Microbiology Letters, vol.230, pp.1-7, 2004.
, Factors Related to Colonization with Oxalobacter formigenes in U.S. Adults, J Endourol, vol.25, pp.673-679, 2011.
, Oxalobacter formigenes May Reduce the Risk of Calcium Oxalate Kidney Stones, J Am Soc Nephrol, vol.19, pp.1197-1203, 2008.
, The role of Oxalobacter formigenes colonization in calcium oxalate stone disease, Kidney International, vol.83, pp.1144-1149, 2013.
, Urinary Oxalate Levels and the Enteric Bacterium Oxalobacter formigenes in Patients with Calcium Oxalate Urolithiasis, European Urology, vol.44, pp.475-481, 2003.
, Intestinal Oxalobacter formigenes Colonization in Calcium Oxalate Stone Formers and Its Relation to Urinary Oxalate, Journal of Endourology, vol.17, pp.173-176, 2003.
, Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation, International Journal of Urology, vol.10, pp.293-296, 2003.
, Oxalobacter formigenes and Its Potential Role in Human Health, Appl Environ Microbiol, vol.68, pp.3841-3847, 2002.
, Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria, Nephrol Dial Transplant, vol.26, pp.3609-3615, 2011.
, A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria, Urolithiasis, vol.46, pp.313-323, 2018.
, A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria -Full Text View -ClinicalTrials, p.20, 2018.
, A Closed Conformation of Bacillus subtilis Oxalate Decarboxylase OxdC Provides Evidence for the True Identity of the Active Site, J. Biol. Chem, vol.279, pp.19867-19874, 2004.
, Hyperoxaluria Is Reduced and Nephrocalcinosis Prevented with an OxalateDegrading Enzyme in Mice with Hyperoxaluria, AJN, vol.29, pp.86-93, 2009.
, A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme, AJN, vol.44, pp.150-158, 2016.
, Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia -Full Text View -ClinicalTrials, p.15, 2018.
, , p.11, 2018.
, The strategy of the genes: a discussion of some aspects of theoretical biology, 1957.
, The Developmental Capacity of Nuclei taken from Intestinal Epithelium Cells of Feeding Tadpoles, Development, vol.10, pp.622-640, 1962.
, Viable offspring derived from fetal and adult mammalian cells, Nature, vol.385, pp.810-813, 1997.
, Expression of a single transfected cDNA converts fibroblasts to myoblasts, Cell, vol.51, pp.987-1000, 1987.
, Present and future challenges of induced pluripotent stem cells, Phil. Trans. R. Soc. B, vol.370, p.20140367, 2015.
, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, vol.126, pp.663-676, 2006.
, Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications, PeerJ, vol.6, 2018.
, Embryonic Stem Cell Lines Derived from Human Blastocysts, Science, vol.282, pp.1145-1147, 1998.
, Generation of Pig Induced Pluripotent Stem Cells with a Drug-Inducible System, J Mol Cell Biol, vol.1, pp.46-54, 2009.
, Generation of Induced Pluripotent Stem Cells from Adult Rhesus Monkey Fibroblasts, Cell Stem Cell, vol.3, pp.587-590, 2008.
, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes, Nat. Biotechnol, vol.26, pp.1276-1284, 2008.
, Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells, Science, vol.321, pp.699-702, 2008.
, Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes To Pluripotency, Cell, vol.133, pp.250-264, 2008.
, Reprogramming of pancreatic beta cells into induced pluripotent stem cells, Curr. Biol, vol.18, pp.890-894, 2008.
, Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors, Nature, vol.454, pp.646-650, 2008.
, Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells, J. Cell. Sci, vol.122, pp.3502-3510, 2009.
, Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.15720-15725, 2009.
, Generation of germline-competent induced pluripotent stem cells, Nature, vol.448, pp.313-317, 2007.
, Generation of human induced pluripotent stem cells from dermal fibroblasts, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.2883-2888, 2008.
, Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells, Science, vol.318, 1917.
, Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4, Cell, vol.95, pp.379-391, 1998.
, Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells, Nat. Cell Biol, vol.9, pp.625-635, 2007.
, Transcriptional regulation of nanog by OCT4 and SOX2, J. Biol. Chem, vol.280, pp.24731-24737, 2005.
, Nanog safeguards pluripotency and mediates germline development, Nature, vol.450, pp.1230-1234, 2007.
, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells, Cell, vol.113, pp.631-642, 2003.
, The biology of the mammalian Krüppel-like family of transcription factors, Int. J. Biochem. Cell Biol, vol.32, pp.1103-1121, 2000.
, Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells, Mol. Cell. Biol, vol.26, pp.7772-7782, 2006.
, The c-Myc target gene network, Semin. Cancer Biol, vol.16, pp.253-264, 2006.
, c-Myc in the control of cell proliferation and embryonic development, Adv. Cancer Res, vol.70, pp.95-144, 1996.
, Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal, Dev. Cell, vol.25, pp.69-80, 2013.
, Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells, Nat. Genet, vol.42, pp.1113-1117, 2010.
, The let-7/LIN-41 Pathway Regulates Reprogramming to Human Induced Pluripotent Stem Cells by Controlling Expression of Prodifferentiation Genes, Cell Stem Cell, vol.14, pp.40-52, 2014.
, Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency, Cell Stem Cell, vol.8, pp.376-388, 2011.
, Suppression of induced pluripotent stem cell generation by the p53-p21 pathway, Nature, vol.460, pp.1132-1135, 2009.
, Senescence impairs successful reprogramming to pluripotent stem cells, Genes Dev, vol.23, pp.2134-2139, 2009.
, Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1, Genes Dev, vol.24, pp.561-573, 2010.
, Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts, Stem Cells, vol.26, 1998.
, Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state, Genes Dev, vol.25, pp.2248-2253, 2011.
, Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds, Cell Stem Cell, vol.3, pp.568-574, 2008.
, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol, vol.26, pp.795-797, 2008.
, Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells, Stem Cells, vol.28, pp.1848-1855, 2010.
, The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner, Cell Stem Cell, vol.9, pp.575-587, 2011.
, Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2, Nat. Biotechnol, vol.26, pp.1269-1275, 2008.
, Generation of induced pluripotent stem cells in the absence of drug selection, Cell Stem Cell, vol.1, pp.245-247, 2007.
, Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts, Nat. Biotechnol, vol.26, pp.101-106, 2008.
, Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions, Stem Cells, vol.28, pp.36-44, 2010.
, Reprogramming of murine and human somatic cells using a single polycistronic vector, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.157-162, 2009.
, Induced pluripotent stem cell generation using a single lentiviral stem cell cassette, Stem Cells, vol.27, pp.543-549, 2009.
, Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors, Cell, vol.136, pp.964-977, 2009.
, A high-efficiency system for the generation and study of human induced pluripotent stem cells, Cell Stem Cell, vol.3, pp.340-345, 2008.
, Reprogramming of peripheral blood cells to induced pluripotent stem cells, Cell Stem Cell, vol.7, pp.20-24, 2010.
, RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications, J Cardiovasc Transl Res, vol.6, pp.956-968, 2013.
, piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells, Nature, vol.458, pp.766-770, 2009.
, Virus free induction of pluripotency and subsequent excision of reprogramming factors, Nature, vol.458, pp.771-775, 2009.
, Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells, Cell, vol.91, pp.501-510, 1997.
, Induced pluripotent stem cells generated without viral integration, Science, vol.322, pp.945-949, 2008.
, Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells, Stem Cells, vol.27, pp.2667-2674, 2009.
, Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system, FASEB J, vol.15, pp.1294-1296, 2001.
, Efficient gene transfer to airway epithelium using recombinant Sendai virus, Nat. Biotechnol, vol.18, pp.970-973, 2000.
, Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes, J Gene Med, vol.10, pp.165-176, 2008.
, Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming, J. Biol. Chem, vol.286, pp.4760-4771, 2011.
, A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression, J Virol, vol.74, pp.6564-6569, 2000.
, Paramyxoviridae: the viruses and their replication. in Fields virology, pp.1177-1204, 1996.
, Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins, J. Virol, vol.77, pp.3238-3246, 2003.
, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci U S A, vol.108, pp.14234-14239, 2011.
, Generation of human induced pluripotent stem cells from cord blood cells, J Stem Cells, vol.6, pp.101-108, 2011.
, Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus, Nat Protoc, vol.7, pp.718-728, 2012.
, Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells, Cell Stem Cell, vol.7, pp.11-14, 2010.
, Efficient induction of transgenefree human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, Proc. Jpn. Acad., Ser. B, vol.85, pp.348-362, 2009.
, Generation of mouse induced pluripotent stem cells without viral vectors, Science, vol.322, pp.949-953, 2008.
, Human induced pluripotent stem cells free of vector and transgene sequences, Science, vol.324, pp.797-801, 2009.
, A nonviral minicircle vector for deriving human iPS cells, Nat. Methods, vol.7, pp.197-199, 2010.
, Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors, Nat Protoc, vol.6, pp.78-88, 2011.
, Requirements for efficient in vitro transcription and translation: a study using yeast invertase as a probe, Biochim. Biophys. Acta, vol.1009, pp.19-26, 1989.
, Synthetic mRNAs with superior translation and stability properties, Methods Mol. Biol, vol.969, pp.55-72, 2013.
, Novel 'anti-reverse' cap analogs with superior translational properties, RNA, vol.9, pp.1108-1122, 2003.
, Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability, Mol. Ther, vol.16, pp.1833-1840, 2008.
, Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA, Immunity, vol.23, pp.165-175, 2005.
, 5'-Triphosphate RNA is the ligand for RIG-I, Science, vol.314, pp.994-997, 2006.
, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, vol.7, pp.618-630, 2010.
, Reprogramming human fibroblasts to pluripotency using modified mRNA, Nat Protoc, vol.8, pp.568-582, 2013.
, Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA, Sci Rep, vol.2, 2012.
, Generation of induced pluripotent stem cells using recombinant proteins, Cell Stem Cell, vol.4, pp.381-384, 2009.
, Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, Cell Stem Cell, vol.4, pp.472-476, 2009.
, Laminin-511 expression is associated with the functionality of feeder cells in human embryonic stem cell culture, Stem Cell Research, vol.8, pp.97-108, 2012.
, Comparative study of mouse and human feeder cells for human embryonic stem cells, Int. J. Dev. Biol, vol.52, pp.353-363, 2008.
, Beware of mycoplasmas, Trends Biotechnol, vol.11, pp.143-151, 1993.
, The development of 'feeder' cells for the preparation of clinical grade hES cell lines: challenges and solutions, J. Biotechnol, vol.125, pp.583-588, 2006.
, The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings, Stem Cells, vol.31, pp.1-7, 2013.
, Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering, J Mater Chem B Mater Biol Med, vol.4, pp.3433-3442, 2016.
, Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma, Biochemistry, vol.21, pp.6188-6193, 1982.
, Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum, BMC Dev. Biol, vol.10, p.60, 2010.
, Chemically defined conditions for human iPSC derivation and culture, Nat. Methods, vol.8, pp.424-429, 2011.
, Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces, Biomaterials, vol.31, pp.9135-9144, 2010.
, Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates, Stem Cells, vol.30, pp.1174-1181, 2012.
, Xeno-free culture of human pluripotent stem cells, Methods Mol. Biol, vol.767, pp.125-136, 2011.
, Footprint-Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical-Grade Cell Source, Stem Cells Transl Med, vol.3, pp.433-447, 2014.
, One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells, Stem Cell Rev and Rep, vol.12, pp.90-104, 2016.
, iPSC Nantes -Plate-forme de cellules souches pluripotentes | Biogenouest, p.7, 2018.
, , p.7, 2018.
, Human embryonic and induced pluripotent stem cells in clinical trials, Br Med Bull, vol.116, pp.19-27, 2015.
, Cellules souches : un nouvel essai chez l'homme. Available at, p.10, 2018.
, & Pm, 3:35. First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson's, Science | AAAS, p.15, 2018.
, Japan conditionally approves new IPS cell-based heart study. The Niche, p.15, 2018.
, Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications, Cold Spring Harb. Symp. Quant. Biol, vol.73, pp.101-110, 2008.
, Generation of functional hepatic cells from pluripotent stem cells, J Stem Cell Res Ther Suppl, vol.10, pp.1-7, 2012.
, Production of hepatocyte like cells from human pluripotent stem cells, Nat Protoc, vol.8, pp.430-437, 2013.
, Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells, J Clin Invest, vol.120, pp.3127-3136, 2010.
, Distinct gene expression signatures in human embryonic stem cells differentiated towards definitive endoderm at single-cell level, Methods, vol.59, pp.59-70, 2013.
, Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst, Proc. Natl. Acad. Sci. U.S.A, vol.91, pp.7598-7602, 1994.
, Scatter factor/hepatocyte growth factor is essential for liver development, Nature, vol.373, pp.699-702, 1995.
, Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways, FEBS Lett, vol.492, pp.90-94, 2001.
, Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control, Genes Dev, vol.10, pp.1670-1682, 1996.
, Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer, EMBO J, vol.18, pp.2127-2136, 1999.
, Differentiation of hepatocytes from pluripotent stem cells, Curr Protoc Stem Cell Biol, vol.26, 2013.
, Highly Efficient Generation of Human Hepatocyte-like Cells from Induced Pluripotent Stem Cells, Hepatology, vol.51, pp.297-305, 2010.
, Vascularized and functional human liver from an iPSC-derived organ bud transplant, Nature, vol.499, pp.481-484, 2013.
, Generation of functional human hepatic endoderm from human induced pluripotent stem cells, Hepatology, vol.51, pp.329-335, 2010.
, The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets, Biomaterials, vol.33, pp.4526-4534, 2012.
, 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing, Biomaterials, vol.34, pp.1781-1789, 2013.
, Induced pluripotent stem cells: a new era for hepatology, J. Hepatol, vol.53, pp.738-751, 2010.
, Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin, Stem Cells Dev, vol.19, pp.1231-1240, 2010.
, Pluripotent stem cell-derived hepatocyte-like cells, Biotechnol. Adv, vol.32, pp.504-513, 2014.
, Hepatocyte-like cells derived from induced pluripotent stem cells, Hepatol Int, vol.11, pp.54-69, 2017.
, Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes, Toxicol. Sci, vol.145, pp.252-262, 2015.
, Long-term chronic toxicity testing using human pluripotent stem cellderived hepatocytes, Drug Metab. Dispos, vol.42, pp.1401-1406, 2014.
, Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.16772-16777, 2014.
, Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells, Hepatology, vol.57, pp.2458-2468, 2013.
, Old drugs learn new tricks, Nat Med, vol.20, pp.590-591, 2014.
, A drug screen using human iPSC-derived hepatocyte-like cells identifies cardiac glycosides as a potential treatment for hypercholesterolemia, Cell Stem Cell, vol.20, 2017.
, Induced pluripotent stem cells model personalized variations in liver disease resulting from ?1-antitrypsin deficiency, Hepatology, vol.62, pp.147-157, 2015.
, Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges, Transfus Med Rev, vol.25, pp.206-216, 2011.
, Toward the Development of a Global Induced Pluripotent Stem Cell Library, Cell Stem Cell, vol.13, pp.382-384, 2013.
, Hepatocyte-like cells derived from induced pluripotent stem cells, Hepatol Int, vol.11, pp.54-69, 2017.
, Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes, Stem Cell Reports, vol.5, pp.22-30, 2015.
, Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin, Hum Mol Genet, vol.20, pp.3176-3187, 2011.
, Targeted gene correction of ?1-antitrypsin deficiency in induced pluripotent stem cells, Nature, vol.478, pp.391-394, 2011.
, DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells, Cell Cycle, vol.7, pp.2902-2906, 2008.
, La recombinaison homologue : de nouvelles perspectives pour la transgenèse chez les mammifères, Médecine sciences [revue papier, vol.6, pp.18-29, 1990.
, Targetted correction of a mutant HPRT gene in mouse embryonic stem cells, Nature, vol.330, pp.576-578, 1987.
, Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells, Mol. Cell. Biol, vol.18, pp.4070-4078, 1998.
, Chimeric nucleases stimulate gene targeting in human cells, Science, vol.300, p.763, 2003.
, Double-strand break end resection and repair pathway choice, Annu. Rev. Genet, vol.45, pp.247-271, 2011.
, CRISPR/Cas9: at the cutting edge of hepatology, Gut, vol.66, pp.1329-1340, 2017.
, Design, activity, and structure of a highly specific artificial endonuclease, Mol. Cell, vol.10, pp.895-905, 2002.
, Gene correction by homologous recombination with zinc finger nucleases in primary cells from a mouse model of a generic recessive genetic disease, Mol. Ther, vol.18, pp.1103-1110, 2010.
, Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV, N. Engl. J. Med, vol.370, pp.901-910, 2014.
, Proven and novel strategies for efficient editing of the human genome, Curr Opin Pharmacol, vol.24, pp.105-112, 2015.
, TALE nucleases: tailored genome engineering made easy, Curr. Opin. Biotechnol, vol.23, pp.644-650, 2012.
, FDA Grants Cellectis IND Approval for UCART22 in B-ALL | Cellectis. Available at, 2018.
, Efficient design and assembly of custom TALEN and other TAL effectorbased constructs for DNA targeting, Nucleic Acids Res, vol.39, p.82, 2011.
, Memory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information, Virology, vol.434, pp.202-209, 2012.
, CRISPR/Cas, the immune system of bacteria and archaea, Science, vol.327, pp.167-170, 2010.
, A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity, Science, vol.337, pp.816-821, 2012.
, Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification, Exp. Biol. Med. (Maywood), vol.240, pp.1065-1070, 2015.
, A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes, PLoS Comput. Biol, vol.1, p.60, 2005.
, Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease, Nature, vol.513, pp.569-573, 2014.
, Improving CRISPR-Cas nuclease specificity using truncated guide RNAs, Nat. Biotechnol, vol.32, pp.279-284, 2014.
, Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, vol.154, pp.1380-1389, 2013.
, Natural zinc ribbon HNH endonucleases and engineered zinc finger nicking endonuclease, Nucleic Acids Res, vol.41, pp.378-390, 2013.
, The RuvC protein dimer resolves Holliday junctions by a dual incision mechanism that involves base-specific contacts, EMBO J, vol.16, pp.1464-1472, 1997.
, CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology, 2014.
, High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells, Nat. Biotechnol, vol.31, pp.822-826, 2013.
, Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects, Nat. Methods, vol.11, pp.399-402, 2014.
, CRISPR-Cas systems for editing, regulating and targeting genomes, Nat. Biotechnol, vol.32, pp.347-355, 2014.
, NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) -Full Text ViewClinicalTrials.gov. Available at, p.26, 2018.
, Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors, p.26, 2018.
, A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent ?-Thalassemia -Full Text View -ClinicalTrials.gov. Available at, p.26, 2018.
, PCSK9: a key modulator of cardiovascular health, Circ. Res, vol.114, pp.1022-1036, 2014.
, CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report, Arterioscler. Thromb. Vasc. Biol, vol.36, pp.783-786, 2016.
, In vivo genome editing using Staphylococcus aureus Cas9, Nature, vol.520, pp.186-191, 2015.
, All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo, Genome Biol, vol.19, p.137, 2018.
, Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease, Sci Rep, vol.7, p.44624, 2017.
, Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I, Sci Rep, vol.6, p.31460, 2016.
, Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia, Nat Commun, vol.7, p.12642, 2016.
, Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy, Mol Ther, vol.24, pp.678-684, 2016.
, Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome, Genome Res, vol.20, pp.1133-1142, 2010.
, Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA, J. Virol, vol.77, pp.9000-9007, 2003.
, Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives, Methods, vol.101, pp.43-55, 2016.
, Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system, Stem Cell Res Ther, vol.9, 2018.
, Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells, Mol Ther Nucleic Acids, vol.5, p.394, 2016.
, CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse, EMBO Mol Med, vol.8, pp.477-488, 2016.
, Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype, Nat. Biotechnol, vol.32, pp.551-553, 2014.
, Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo, Nat. Biotechnol, vol.34, pp.328-333, 2016.
, CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells, Hepatol Commun, vol.1, pp.886-898, 2017.
, Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation, Stem Cell Research, vol.16, pp.116-119, 2016.
, CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing, Nucleic Acids Res, vol.42, pp.401-407, 2014.
, CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells, Exp Hematol, vol.43, pp.838-848, 2015.
, Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA, Journal of Biotechnology, vol.241, pp.136-146, 2017.
, Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics, Cell Stem Cell, vol.14, pp.13-26, 2014.
, Three-dimensional biomaterials for the study of human pluripotent stem cells, Nat. Methods, vol.8, pp.731-736, 2011.
, Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells, Stem Cell Rev, vol.6, pp.248-259, 2010.
, Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture, Stem Cells Dev, vol.22, pp.2693-2705, 2013.
, Genome maintenance in pluripotent stem cells, J Cell Biol, vol.204, pp.153-163, 2014.
, Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells, PLoS Genet, vol.13, 2017.
, Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts, PLoS ONE, vol.5, p.13017, 2010.
, Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery, Nature Methods, vol.13, pp.41-50, 2016.
, Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage, Nucleic Acids Res, vol.43, pp.8924-8941, 2015.
, Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA, Genome Res, vol.24, pp.1020-1027, 2014.
, Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins, Genome Res, vol.24, pp.1012-1019, 2014.
, Rationally engineered Cas9 nucleases with improved specificity, Science, vol.351, pp.84-88, 2016.
, Enhancing Cas9 Activity in Heterochromatin, p.228601, 2017.
, The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells, ACS Synth Biol, vol.6, pp.428-438, 2017.
, Relaxed chromatin induced by histone deacetylase inhibitors improves the oligonucleotide-directed gene editing in plant cells, J. Plant Res, vol.131, pp.179-189, 2018.
, Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing, FEBS J, vol.282, pp.4289-4294, 2015.
, Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing, Genome Med, vol.7, 2015.
, Inhibition of non-homologous end joining increases the efficiency of CRISPR/Cas9-mediated precise, Nat Biotechnol, vol.33, pp.538-542, 2015.
, Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells, Nature Biotechnology, vol.33, pp.543-548, 2015.
, Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases, Cell Reports, vol.14, pp.2263-2272, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01371505
, Microbial-derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells-derived and fetal hepatocytes, Hepatology, vol.62, pp.265-278, 2015.
, Pregnane X receptor and drug-induced liver injury, Expert Opin Drug Metab Toxicol, vol.10, pp.1521-1532, 2014.
, Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction, PLoS ONE, vol.6, p.21780, 2011.
, Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4? transduction, Mol. Ther, vol.20, pp.127-137, 2012.
, Hepatic differentiation of human iPSCs in different 3D models: A comparative study, Int J Mol Med, vol.40, pp.1759-1771, 2017.
, Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture, PLoS One, vol.9, 2014.
, InVERT molding for scalable control of tissue microarchitecture, Nat Commun, vol.4, p.1847, 2013.
, Fabrication of a co-culture micro-bioreactor device for efficient hepatic differentiation of human induced pluripotent stem cells (hiPSCs), Nanomedicine, and Biotechnology, vol.0, pp.1-10, 2018.
, Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cells, Biochemical and Biophysical Research Communications, vol.496, pp.1269-1275, 2018.
, Decellularized human liver extracellular matrix (hDLM)-mediated hepatic differentiation of human induced pluripotent stem cells (hIPSCs)
, J Tissue Eng Regen Med, vol.12, pp.1962-1973, 2018.
, Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments, Stem Cells Transl Med, vol.5, pp.1257-1267, 2016.
, Generation of a vascularized and functional human liver from an iPSCderived organ bud transplant, Nat Protoc, vol.9, pp.396-409, 2014.
, Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells, EBioMedicine, vol.0, 2018.
, Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold, Biomaterials, vol.182, pp.299-311, 2018.
, Etanercept blocks inflammatory responses orchestrated by TNF-? to promote transplanted cell engraftment and proliferation in rat liver, Hepatology, vol.60, pp.1378-1388, 2014.
, Endothelin-1 receptor A blocker darusentan decreased hepatic changes and improved liver repopulation after cell transplantation in rats, Hepatology, vol.59, pp.1107-1117, 2014.
, Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglandin-endoperoxide synthase inhibition, Gastroenterology, vol.136, pp.2356-2364, 2009.
, Integrin and Extracellular Matrix Interactions Regulate Engraftment of Transplanted Hepatocytes in the Rat Liver, Gastroenterology, vol.129, pp.1643-1653, 2005.
, Regional Transient Portal Ischemia and Irradiation as Preparative Regimen for Hepatocyte Transplantation, Cell Transplant, vol.20, pp.303-312, 2011.
, Hepatocyte transplantation and drug-induced perturbations in liver cell compartments, Hepatology, vol.47, pp.279-287, 2008.
, Loss of p27Kip1 enhances the transplantation efficiency of hepatocytes transferred into diseased livers, J Clin Invest, vol.108, pp.383-390, 2001.
, Hippo Pathway Activity Influences Liver Cell Fate, Cell, vol.157, pp.1324-1338, 2014.
, Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro, Cell Med, vol.4, pp.85-98, 2012.
, Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates, Hepatology, vol.49, pp.950-959, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00326130
,
, Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.; Hum Mol Genet, vol.26, pp.1565-1576, 2017.
, AGXT expression rescue in hepatocyte-like cells derived from Primary Hyperoxaluria type 1 induced pluripotent stem cells using liver-specific lentiviral vector, 2018.
, Targeted gene therapy in human induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using the CRISPR/Cas9 technology
,
, Targeted gene editing for phenotypic correction of Primary Hyperoxaluria type 1, Congrès et formations 25th Anniversary Congress of the European Society, vol.17, 2017.
, Concevoir une stratégie de veille : collecter, classer, sauvegarder et diffuser ses données, INGESTEM (Infrastructure nationale d'ingénierie des cellules souches pluripotentes, pp.8-09, 2015.
, L'industrie pharmaceutique : perspectives pour les jeunes chercheurs, pp.3-04, 2015.